US PRE-MARKET MOVERS: JEF, AIR, SMMT, GS, AMD, PEP, QURE
US pre-market futures gained slightly while individual equities traded on major M&A, AstraZeneca's investment in SMMT, Goldman Sachs succession discussions, and uniQure's clinical data update.
News detail
ES +0.2% NQ +0.3% RTY +0.4% JEF -0.1%: Choppy post-earnings; sharp decline in asset mgmt. rev. & weaker FI trading but saw record equity trading & IB rev. w/ a profit beat AIR +8%: Agreed to buy a 65% stake in aircraft maintenance Co. MRO Holdings for $1.8bln SMMT +15.5%: AstraZeneca will invest $2bln GS +0.3%: Board discussed replacing CEO David Solomon w/ President & COO John Waldron around end-2027 or 2028 AMD +1.2%: To acquire World Labs for $8.2bln in all stock transaction PEP -0.7%: Downgraded at JPM on stalled US turnaround QURE -65%: Cos. Gene therapy continues to slow Huntington’s progression after four years, but magnitude of treatment’s benefit waned vs. similar analysis a year ago
Related stocks
9 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
